SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-299401
Filing Date
2020-11-20
Accepted
2020-11-20 16:10:54
Documents
9
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A d847937dpre14a.htm PRE 14A 992523
3 GRAPHIC g847937g01b88.jpg GRAPHIC 197680
4 GRAPHIC g847937g02f96.jpg GRAPHIC 174746
5 GRAPHIC g847937g14n45.jpg GRAPHIC 92830
6 GRAPHIC g847937g20m47.jpg GRAPHIC 108867
7 GRAPHIC g847937g40b45.jpg GRAPHIC 96574
8 GRAPHIC g847937g83t26.jpg GRAPHIC 26677
9 GRAPHIC g847937img01.jpg GRAPHIC 4239
10 filename10.htm CORRESP 6624
  Complete submission text file 0001193125-20-299401.txt   1953105
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36483 | Film No.: 201332604
SIC: 8071 Services-Medical Laboratories